Rivaroxaban for treatment of pediatric venous thromboembolism: An Einstein-Jr phase 3 dose-exposure-response evaluation

MLA

Ida Martinelli, et al. Rivaroxaban for Treatment of Pediatric Venous Thromboembolism: An Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation. July 2020. EBSCOhost, https://doi.org/10.1111/jth.14813⟩.

APA

Ida Martinelli, Kirstin Thelen, Riten Kumar, Ildar Nurmeev, Anthony K.C. Chan, Susanne Holzhauer, Helene L. Hooimeijer, Victoria E. Price, Christoph Male, Marcela Torres, Guy Young, Kerry Hege, Scott D. Berkowitz, Philip Connor, Gili Kenet, Joseph S. Palumbo, M. Patricia Massicotte, William T. Smith, Stephan Schmidt, … Anthonie W. A. Lensing. (2020). Rivaroxaban for treatment of pediatric venous thromboembolism: An Einstein-Jr phase 3 dose-exposure-response evaluation. https://doi.org/10.1111/jth.14813⟩

Chicago

Ida Martinelli, Kirstin Thelen, Riten Kumar, Ildar Nurmeev, Anthony K.C. Chan, Susanne Holzhauer, Helene L. Hooimeijer, et al. 2020. “Rivaroxaban for Treatment of Pediatric Venous Thromboembolism: An Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation,” July. doi:10.1111/jth.14813⟩.